Press release BoxID: 621046 (Sonova Holding AG)
  • Sonova Holding AG
  • Laubisrütistrasse 28
  • 8712 Stäfa
  • Contact person
  • Thomas Bernhardsgrütter
  • +41 (58) 92833-44

Advanced Bionics announces FDA approval of new sound processor

(PresseBox) (Staefa, ) Sonova Holding AG, the world's leading provider of hearing solutions, announces today that its subsidiary Advanced Bionics (AB) has received FDA (Food and Drug Administration) approval in the United States for its new Naída CI Q70 (Naída CI) sound processor. With this approval, the product is now commercially available in the United States. Earlier this year, the Naída CI processor received regulatory approval for distribution in Europe, Canada and several other countries in the world.

With Naída CI, the innovation DNA of AB and Phonak have merged together for the introduction of the world's newest, most advanced behind-the-ear sound processor. Now cochlear implant recipients have access to the combined technologies of the innovation leaders in cochlear implants and hearing instruments.

Naída CI comes with a full performance package in a small size. Significantly improved speech perception, unique ear-to-ear communication and 100% wireless connectivity to consumer electronics together with a 40% size reduction compared to AB's previous behind-the-ear processor are just a few of the new processor's myriad of features. For more information, please visit


This Media Release contains forward-looking statements, which offer no guarantee with regard to future performance. These statements are made on the basis of management's views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside Sonova's control. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Each forward-looking statement speaks only as of the date of the particular statement, and Sonova undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.

Sonova Holding AG

Sonova Holding AG, headquartered in Staefa, Switzerland, is the leading manufacturer of innovative hearing care solutions. The group operates through its core business brands Phonak, Unitron, Advanced Bionics and Connect Hearing. Sonova offers its customers one of the most comprehensive product portfolios in the industry - from hearing instruments to cochlear implants to wireless communication solutions. Founded in 1947, the group is currently present in over 90 countries across the globe and has a workforce of almost 9,000 dedicated employees. Sonova generated sales of CHF 1.8 billion in the financial year 2012/13 and a normalized net profit of CHF 309 million. By supporting the Hear the World Foundation, Sonova pursues its vision of a world where everyone enjoys the delight of hearing and therefore lives a life without limitations.

For more information please visit